Havn Life Sciences Stock Market Value
| HAVLF Stock | USD 0.0001 0.00 0.00% |
| Symbol | HAVN |
HAVN Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HAVN Life's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HAVN Life.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in HAVN Life on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding HAVN Life Sciences or generate 0.0% return on investment in HAVN Life over 90 days. HAVN Life is related to or competes with Zelira Therapeutics, Ayala Pharmaceuticals, Sigyn Therapeutics, and Talis Biomedical. HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological produ... More
HAVN Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HAVN Life's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HAVN Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1122 | |||
| Maximum Drawdown | 1894.74 |
HAVN Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HAVN Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HAVN Life's standard deviation. In reality, there are many statistical measures that can use HAVN Life historical prices to predict the future HAVN Life's volatility.| Risk Adjusted Performance | 0.0993 | |||
| Jensen Alpha | 28.21 | |||
| Total Risk Alpha | 12.98 | |||
| Treynor Ratio | (0.34) |
HAVN Life February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | (0.33) | |||
| Mean Deviation | 55.75 | |||
| Coefficient Of Variation | 889.54 | |||
| Standard Deviation | 222.81 | |||
| Variance | 49644.4 | |||
| Information Ratio | 0.1122 | |||
| Jensen Alpha | 28.21 | |||
| Total Risk Alpha | 12.98 | |||
| Treynor Ratio | (0.34) | |||
| Maximum Drawdown | 1894.74 | |||
| Skewness | 8.01 | |||
| Kurtosis | 64.81 |
HAVN Life Sciences Backtested Returns
HAVN Life is out of control given 3 months investment horizon. HAVN Life Sciences holds Efficiency (Sharpe) Ratio of 0.0943, which attests that the company had a 0.0943 % return per unit of volatility over the last 3 months. We were able to break down and interpolate sixteen different technical indicators, which can help you to evaluate if expected returns of 12.35% are justified by taking the suggested risk. Use HAVN Life Sciences coefficient of variation of 889.54, and Market Risk Adjusted Performance of (0.33) to evaluate company specific risk that cannot be diversified away. HAVN Life holds a performance score of 7 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -73.75, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HAVN Life are expected to decrease by larger amounts. On the other hand, during market turmoil, HAVN Life is expected to outperform it. Use HAVN Life Sciences standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on HAVN Life Sciences.
Auto-correlation | 0.00 |
No correlation between past and present
HAVN Life Sciences has no correlation between past and present. Overlapping area represents the amount of predictability between HAVN Life time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HAVN Life Sciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current HAVN Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in HAVN Pink Sheet
HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.